Costa : Investor presentation - full year results

CY21 Results

Presentation

onlyCosta Group Holdings Ltd

use(ASX:CGC)

ersonal22 February 2022

Important Notice

▪ Important notice and disclaimer:. This presentation contains a general summary of the activities of Costa Group Holdings Ltd (Costa), does not purport to be complete and is to be read in conjunction with all other

only	announcements filed with the Australian Securities Exchange (ASX), including Costa's CY21 results filed with the ASX on 22 February 2022 and its 2020 Annual Report filed with the ASX on 14 April 2021. Information in this
presentation is current as at the date of this presentation (22 February 2022) and remains subject to change without notice. Costa does not warrant the accuracy, adequacy or reliability of the information in this presentation and,
to the maximum extent permitted by law, disclaims all liability and responsibility flowing from the use of or reliance on such information by any person.
▪ Not an offer or financial product advice: This presentation is not investment or financial product advice or any recommendation (nor tax, accounting or legal advice) and is not intended to be used as the basis for making an
	investment decision. In providing this document, Costa has not considered the objectives, financial position or needs of any particular recipients. Each recipient should consult with its professional adviser(s), conduct its own
	investigation and perform its own analysis in order to satisfy themselves of the accuracy and completeness of the information, statements and opinions contained in this document. This presentation does not constitute an offer
	to issue or sell securities or other financial products in any jurisdiction. The distribution of this presentation outside Australia may be restricted by law.

▪ Forward looking statements: This presentation contains forward looking statements and comments about future events, which reflect Costa's intent, belief or expectation as at the date of this presentation. Such forward looking

use	statements may include forecast financial and operating information about Costa, its projects and strategies and statements about the industries and locations in which Costa operates. Forward looking statements can be
identified by forward-looking terminology including, without limitation, "expect", "anticipate", "likely", "intend", "should", "could", "may", "predict", "plan", "propose", "will", "believe", "forecast", "estimate", "target" and other

similar expressions within the meaning of securities laws of applicable jurisdictions. Indications of, and guidance or outlook on, future earnings or financial position or performance are also forward looking statements. Forward looking statements involve inherent known and unknown risks, uncertainties and contingencies, both general and specific, many of which are beyond Costa's control, and there is a risk that such predictions, forecasts, projections and other forward looking statements will not be achieved. Actual results may be materially different from those expressed or implied. Forward looking statements are provided as a general guide only and should not be relied on as an indication, representation or guarantee of future performance. Undue reliance should not be placed on any forward looking statement. Costa does not undertake to update or review any forward looking statements.

▪ Past performance: Past performance should not be relied upon as (and is not) an indication or guarantee of Costa's future performance or condition.

▪ Financial data: All dollar values are in Australian dollars ($ or A$) unless stated otherwise.

ersonal▪

Non-IFRSmeasures: Throughout this presentation, Costa has included reference to certain non-IFRS measures. Non-IFRS measures have not been subject to audit. A further explanation of these measures is provided in the Appendix.

CY21 Results
Presentation	2

CY21 Key Highlights

Earnings momentum continued: 27% of sales now generated from International customers.

only	o Full year underlying result delivered in line with guidance EBITDA-S +10.6%1 vs
	pcp, NPAT-S +16.2%.1
use	o Record result from international segment +30% revenue growth.
o Transformative Citrus year with successful 2PH integration.
o	Successful COVID-19 management enhanced our customer value proposition.
ersonal
	1. Includes 2PH profit contribution. Excluding 2PH, EBITDA-S increase was 4.1%, whilst NPAT-S increase was 6.0% vs pcp.
CY21 Results	3
Presentation

ROIC - Return on invested capital

CY21 Results

Presentation

Key Messages

Our business model is designed to deliver increased earnings and ROIC over the long term.

onlyThis includes leveraging our competitive advantages driven by:

1. Scale and geographical diversity - domestic and international.

o Increased production capacity through organic growth and

use		acquisitions.
o IP and proprietary variety breeding program.
o Lower cost of production at key sites.
o	Expanding contribution to revenue growth from international and
ersonal		export activity.
o	Unrelenting focus on our customer and consumer needs,

supported by quality and diversity of product offering.

4

CY21 Financial Headlines

only

EBITDA-S: $218.2m1 +10.6% on CY20

NPAT-S: $64.0m +16.2% on CY20

Statutory NPAT: $41.4m

Net debt: $299.2m, leverage of 1.85x

International revenue: +30% vs pcp

Dividend: 5.0 cents per share

ersonal use

Transacted Sales ($m))

1,598.6	1,658.9
CY20	CY21
1. Includes 2PH contribution of $12.9m

CY21 Results

Presentation

Total Revenue ($m)	EBITDA-S ($m)		NPAT-S ($m)
	1,220.6	197.2	218.2		64.0
1,164.9
			55.1
CY20	CY21	CY20	CY21	CY20	CY21

5